The global allergy treatment market has been gaining traction over the past few years owing to the increasing prevalence of allergic diseases. Allergies are adverse immune responses or hypersensitivities to foreign substances such as pollen, pet dander, dust mites, and certain foods. Common types of allergies include asthma, allergic rhinitis, conjunctivitis, food allergies, skin allergies, etc. Rising pollution levels, changing lifestyle patterns, increase in healthcare expenditure, and greater awareness regarding treatment options are some of the key factors fueling the growth of the allergy treatment market. The market offers a wide range of treatment options including antihistamines, decongestants, corticosteroids, immunotherapy, and epinephrine auto-injectors. The Global Allergy Treatment Market Size is estimated to be valued at US$ 23048.97 Mn in 2024 and is expected to exhibit a CAGR of 6.9% over the forecast period 2024 to 2030.

Key Takeaways

Key players operating in the allergy treatment are Amcor PLC, Blisters Inc., Honeywell International Inc., Blisterpak Inc., VisiPak, Sonoco Products Company, Powerpak Industries L.L.C., Clearwater Packaging Inc., Constantia Flexibles GmbH, Westrock Company, and Algus Packaging Inc. These players are engaged in developing advanced packaging solutions to maintain drug stability and enhance patient compliance.

The growing demand for allergy treatments can be attributed to the rising global prevalence of allergic diseases. According to an updated report released by the World Allergy Organization in 2016, over 200 million individuals are under allergy treatment worldwide. The high unmet needs of allergic patients are encouraging manufacturing and development of innovative therapies.

The global expansion of key players through mergers and acquisitions is another major driver of market growth. Established players are expanding their geographical presence to leverage lucrative opportunities in emerging Asian, Latin American, and Middle Eastern markets. For instance, in 2019, Amcor acquired Bemis to become the largest consumer packaging company globally with combined sales of US$ 15 billion.

Market Drivers

Rising allergies around the world is the major growth driver for this market. The increasing pollution levels and changing environmental conditions have contributed to the growth in allergies globally. According to a report published by the CDC (Center for Disease Control and Prevention), allergies are affecting over 50 million Americans currently with an addition of 2.1 million patients per year. This rising patient base is fueling the demand for various allergy medications driving market growth. Other factors such as changing lifestyles, increasing healthcare expenditures, growing awareness and technological advancements are also aiding the growth of the global allergy treatment market over the forecast period.

Current global geopolitical tensions could impact the growth of the allergy treatment market over the forecast period. Rising political and trade conflicts between major economies create uncertainties that negatively influence business confidence and investment decisions. This leads pharmaceutical companies to delay or curb new product launches and ramping up of production capacities. Supply chain disruptions arising from sanctions and restricted trade between certain nations can limit the availability of critical raw materials for new drugs. Nevertheless, increasing prevalence of allergic diseases worldwide driven by environmental factors ensures persistent demand. To counter geopolitical headwinds, companies may focus on regionalizing manufacturing footprints and building multiple supplier networks. Identifying new sources of raw ingredients and developing substitutes can help boost resilience of supply chains. Further collaboration between nations on health issues can potentially reduce restrictions on movement of essential medicines in times of conflicts.

North America currently accounts for the largest share of the global allergy treatment market in terms of value. According to estimates, the region represented over 40% revenue share in 2024 owing to high awareness levels, strong presence of key pharmaceutical players and favorable reimbursement policies. Growing healthcare expenditure per capita and expanding patient pool indicate continued growth opportunities. Meanwhile, Asia Pacific exhibits strong growth potential and is identified as the fastest growing regional market over the forecast period. Factors such as rising living standards, shift towards pharmaceutical therapies and increasing healthcare investments by regional governments are contributing to the rapid expansion of the allergy treatment market in Asia Pacific. China, India and other Southeast Asian economies will be the focus of major pharmaceutical companies given improving access to diagnoses and treatments.

Get More Insights on This Topic: https://www.newsanalyticspro.com/allergy-treatment-market-size-share-and-growth-forecast-2024-2030/